Description of the medicine: Pufemid (Puphemidum)
PUFEMID (Puphemidum). 3- (para-Isopropoxyphenyl) succinimide.
White powder with a slightly yellowish tint. It is practically insoluble in water. Soluble in alcohol.
Like ethosuximide, it is a derivative of succinic acid imide. In structure, it differs from ethosuximide in that instead of methyl and ethyl at the nitrogen atom in position 3 it contains a para-substituted phenyl radical.
Like other drugs of this group (succinimides) it has anticonvulsant activity. It is used in case of petit mal epilepsy, as well as in temporal lobe epilepsy.
Take orally before meals. Dose for adults - starting from 0.25 g 3 times a day; with insufficient effect, the dose is increased to 1.5 g per day. Children under the age of 7 years are prescribed 0.125 g, older than 7 years - 0.25 g 3 times a day.
Pufemid can be used in combination with other antiepileptic drugs.
Possible side effects are nausea, insomnia. In case of nausea, it is recommended to take the drug 1-1.5 hours after eating, in case of sleep disturbance - no later than 3-4 hours before bedtime.
The drug is contraindicated in acute diseases of the liver and kidneys, diseases of the hematopoietic system, with hyperkinesis, severe atherosclerosis.
Release form: tablets of 0.25 g in a package of 50 pieces.
Storage: List B. In banks of orange glass.